Clinical Trials Browser

Phase 1/2 × Lymphoma, T-Cell, Peripheral × Bortezomib × Clear all

NCT04068597 2025-12-18

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms

NCT00374699 2009-10-14

Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas

Phase 1/2 Completed

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral